We serve Chemical Name:5-Methylisocytidine CAS:159639-80-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Methylisocytidine
CAS.NO:159639-80-2
Synonyms:2-Amino-5-methyl-1-(β-D-ribofuranosyl)-4(1H)-pyrimidinone;4(1H)-Pyrimidinone, 2-amino-5-methyl-1-β-D-ribofuranosyl-;MFCD25542469
Molecular Formula:C10H15N3O5
Molecular Weight:257.243
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:537.5±60.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.725
PSA:
Exact Mass:257.101166
LogP:-1.35
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-Amino-5-methyl-1-(β-D-ribofuranosyl)-4(1H)-pyrimidinone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD25542469 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD25542469 Use and application,MFCD25542469 technical grade,usp/ep/jp grade.
Related News: Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. 5-Methylisocytidine manufacturer On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday. 5-Methylisocytidine supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 5-Methylisocytidine vendor Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list. 5-Methylisocytidine factory ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.
